The clinical trials below are available in the specialty you selected. Choose a different specialty.
A randomized, double-blind, placebo controlled study to assess the efficacy of LCQ908 on cardiovascular risk
This study is a proof of concept to determine if an investigational drug called LCQ908 can reduce triglyceride levels and lessen cardiovascular risk in people with cardiovascular disease. (REF# 35097)
We are recruiting subjects for a clinical trial of exercise and stress management called ENHANCED. (REF# 15896)
Lifestyle, Cardiovascular Disease Risk, and Cognitive Impairment
Adults older than age 55 are needed for a study examining how exercise and diet improve cognitive function. (REF# 31464)
Patients with poorly controlled blood sugars are needed for a study to examine the effects of exenatide on type 2 diabetes and cardiovascular disease. (REF# 25038)